We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Absolute Bioavailability of Reslizumab in Healthy Subjects

- Absolute Bioavailability
- Completed

Study Title: Absolute Bioavailability of Reslizumab in Healthy Subjects

Teva Identifier: C38072/1107

ClinicalTrials.gov Identifier: NCT01990443

Study Status: Completed

Trial Condition(s): Absolute Bioavailability

Interventions: Drug: Reslizumab IV | Drug: Reslizumab SC

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

disease icon for clinical trials

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years to 45 Years

Trial Duration: 06/01/2013 - 03/01/2014

Phase: Phase 1

Study Type

Interventional